| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 14.276 | 19.220 | 15.307 | 9.765 | 12.556 | 12.197 | 7.830 | 11.857 | 10.537 | 9.741 |
| Total Income - EUR | 14.524 | 19.307 | 15.574 | 9.775 | 12.556 | 12.197 | 7.940 | 11.858 | 10.537 | 9.748 |
| Total Expenses - EUR | 14.247 | 12.293 | 13.724 | 5.397 | 4.842 | 10.107 | 10.796 | 11.984 | 16.261 | 14.012 |
| Gross Profit/Loss - EUR | 277 | 7.014 | 1.849 | 4.378 | 7.714 | 2.090 | -2.856 | -126 | -5.724 | -4.265 |
| Net Profit/Loss - EUR | -153 | 6.438 | 1.471 | 4.256 | 7.588 | 1.876 | -3.070 | -475 | -5.724 | -4.265 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Bioterm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.481 | 759 | 129 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 6.090 | 4.499 | 5.389 | 7.105 | 10.413 | 12.376 | 9.061 | 8.436 | 11.601 | 7.096 |
| Inventories | 2.536 | 2.636 | 3.969 | 4.649 | 3.632 | 6.172 | 6.358 | 5.216 | 4.178 | 3.482 |
| Receivables | 1.631 | 611 | 1.026 | 445 | 448 | 1 | 8 | 759 | 734 | 5 |
| Cash | 1.923 | 1.252 | 394 | 2.011 | 6.333 | 6.203 | 2.695 | 2.461 | 6.689 | 3.610 |
| Shareholders Funds | -9.570 | -3.035 | -1.513 | 2.771 | 10.305 | 11.985 | 8.650 | 8.202 | 2.452 | -1.826 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 17.162 | 8.292 | 7.031 | 4.334 | 109 | 390 | 411 | 234 | 9.178 | 8.938 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "113 - 113" | |||||||||
| CAEN Financial Year |
113
|
|||||||||
Comments - Bioterm S.r.l.